The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

Recruiting now · Phase 2

Conditions studied: Pleural Mesothelioma, Pleural Diseases, Cancer, FAPI, Fibroblast Activation Protein Inhibitor

In brief

Seventy (N=70) patients with suspected pleural mesothelioma (PM) lesions referred to pleural biopsy will be recruited, and undergo an additional FAPI PET/CT at primary staging. The FAPI PET/CT results will be compared to conventional imaging (including FDG PET/CT). The diagnostic accuracy will be determined with histopathology as reference standard. For patients undergoing anticancer treatment (chemotherapy, immunotherapy, other treatment), an additional FAPI PET/CT and an additional FDG PET/CT will be conducted after the study subjects have completed 2-3 series of anticancer treatment. The feasabilitiy of FAPI PET/CT in response evaluation will be investigated. All study specific analyzes will be blinded and will not influence the patient management / treatment.

Key facts

Study ID

NCT06790082

Run by

Aalborg University Hospital

People needed

70

Starts

2025-01-29

Expected to finish

2037-04-30

Last updated by the study team

2025-07-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with pleural lesions suspicious of pleural mesothelioma and referred to pleural biopsy.
• Undergone/undergoing FDG PET/CT as part of the diagnostic workup of a suspicious PM lesion.
• Considered physically and mentally able to participate in the research project.
• Understands the study subject information and able to consent to project participation.
• 18-years or older

You may not qualify if…

• Patients with an imminent need for surgery or in an emergency
• Known concurrent other malignancy with active treatment within the last 1 year; non-melanoma skin cancer and cervical cancer in situ are exempt.
• Pregnant or breastfeeding women.
• Fertile women (women of childbearing potential) who could - theoretically - be pregnant (i.e., unknown pregnancy status).
• Fertile women will be tested for pregnancy (by urine humane choriogonadotropin (HCG) or serum HCG) within 48h before FAPI PET/CTs, both at primary staging and restaging. Study subjects can participate in the study if the pregnancy test is negative (i.e., not pregnant).
• Subjects unable to undergo PET/CT: e.g., weighing more than 180 kg (weight limit scanner), unable to fit within the imaging gantry, inability to remain still for the duration of the examination, or with known severe claustrophobia unresponsive to oral anxiolytics or severe fear of needles.
• Subjects with any medical condition or other circumstances that, in the opinion of the Investigator, would significantly decrease the reliability of data, achievement of study objectives or completing the study.
• History of allergic reactions / hypersensitivity attributed to [18F]FDG or FAPI-tracers.

Where it is running

• Aalborg University Hospital — Aalborg, Region North Jutland, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.